RoboCT Reveals an Exoskeleton Technology Ecosystem at CES 2026
At CES 2026, RoboCT presents a vision that goes beyond single products. The Chinese exoskeleton leader outlines a strategic blueprint for a full-lifecycle mobility ecosystem. RoboCT anchors this plan in its innovative "Rehabilitation-as-a-Service" (RaaS) model and its vision for exoskeletons as augmentative human "new organs."
"CES marks our strategic transition from a focused medical device innovator to an enabler of human mobility across the lifespan and scenarios," stated Dr WANG Tian, Founder and CEO of RoboCT. "We are showcasing not just the GoGo product line, but an integrated system where hardware, data, and professional services converge to deliver continuous, personalised support from hospital to home."
RoboCT builds this exoskeleton technology ecosystem around its pioneering RaaS model. The platform integrates exoskeleton devices with a cloud-based intelligence centre. It enables real-time data monitoring, remote therapist oversight, and personalised adjustments to the training programme. This digital continuum extends rehabilitation beyond the clinic and into community and home settings. It also improves access and supports better recovery outcomes.
RoboCT bases this expansion on a strong track record in medical exoskeletons and rehabilitation robotics. China’s NMPA certified RoboCT’s medical-grade exoskeletons for neurological rehabilitation among the first in the country. RoboCT holds an intellectual property portfolio of more than 500 patents. The company also led the formulation of multiple national and industry standards for exoskeleton robots. RoboCT designed its new manufacturing base in Wuxi to scale production for consumer-ready mobility support, including the GoGo series. The company aims to deliver high performance at accessible costs.
RoboCT also sets out a bold "Human+" direction for robotic exoskeletons. The company explores applications beyond healthcare, including industrial support that helps prevent worker injury, wellness solutions for active ageing, and performance enhancement for outdoor recreation. RoboCT expects exoskeleton technology to become smaller and smarter over time. It also expects people to adopt it as a seamless, low-risk enhancement to human capability, as an intuitive "new organ" for the modern era.
By presenting this ecosystem strategy at CES, RoboCT positions itself at the forefront of a broader industry shift. The company moves beyond device sales and builds a future that normalises robotic assistance. RoboCT aims to enhance quality of life, boost productivity, and expand human potential on a global scale.